Related Experiment Video
Updated: Sep 1, 2025
09:09
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
6.1K
Cell membrane coated-nanoparticles for cancer immunotherapy
Yingping Zeng1, Sufen Li1, Shufen Zhang1
1College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, China.
Acta Pharmaceutica Sinica. B
|August 15, 2022
Summary
Cell membrane-coated nanoparticles (CMCNs) offer a promising approach to overcome limitations in cancer immunotherapy by enhancing drug delivery and immune response. These biomimetic nanoparticles improve compatibility and targeting for better cancer treatment outcomes.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Cancer immunotherapy shows promise but faces challenges like tumor heterogeneity and immunosuppression.
- Existing immunotherapies are limited by toxicity and effectiveness.
- Cell membrane-coated nanoparticles (CMCNs) offer unique properties for cancer treatment.
Purpose of the Study:
- To review recent advancements in biomimetic CMCNs for cancer immunotherapy.
- To explore the functions and mechanisms of CMCNs in cancer treatment.
- To analyze the clinical translation challenges for CMCNs.
Main Methods:
- Literature review of CMCNs in cancer immunotherapy.
- Analysis of CMCN properties including biocompatibility, targeting, and immune interactions.
- Exploration of molecular mechanisms and clinical applications.
Main Results:
- CMCNs inherit cell-like functions, enhancing biocompatibility and immune evasion.
- CMCNs demonstrate improved drug delivery, circulation time, and tumor targeting.
- Biomimetic CMCNs show potential to overcome current cancer immunotherapy limitations.
Conclusions:
- CMCNs represent a significant advancement in cancer immunotherapy delivery systems.
- Further research is needed to address challenges in clinical translation.
- CMCNs hold great potential for improving cancer treatment efficacy and safety.
Related Concept Videos
01:27Tumor Immunotherapy
646
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
646
01:30Cancer Vaccines
499
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
499
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K